DNA Polymerase Market Business Opportunities, Values, Supply-Demand, and Brand Shares and Forecast 2021-2027 | Thermo Fisher Scientific Inc., Agilent Technologies Inc. | FMI Report
DNA polymerase is a unique Pyrococcus-like proofreading enzyme fused to the Sso7d dsDNA-binding protein to create a thermostable fusion polymerase that accurately amplifies long products from a variety of DNA templates. High-fidelity PCR enzymes are used for applications requiring high accuracy during DNA amplification such as sequencing, cloning, or mutagenesis.
Future Market Insights presents a detailed forecast and in-depth insights on the global DNA Polymerase Market in a new report titled ‘DNA Polymerase Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027).’ According to the report, the global DNA polymerase market is anticipated to record a compounded annual growth rate of 6.5% and reach a market value of US$ 389.4 Mn in 2027.
Factors Impacting Market Revenue Growth
Staggering increase in the use of DNA polymerases in point-of-care and molecular diagnostics kits is expected to continue to influence the adoption of DNA polymerases. Increasing use of DNA polymerases in epigenetics research, in addition to the increasing investments in life sciences R&D is also expected to boost revenue growth of the global market. However, high cost of reagents and availability of alternative techniques are expected to limit market growth over the forecast period.
Get Sample of this Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-801
Global DNA Polymerase Market: Segmental Analysis & Forecast
By product type, growth of the eukaryotic DNA polymerase segment will be positively impacted by the introduction of various innovative products such as high-fidelity DNA polymerase that show excellent results in whole blood and other samples containing crude lysates. These products have been used in direct PCR applications, with limited sample processing, which have been a constant requirement especially for high throughput applications. In addition, the use of PCR-based technologies in point-of-care tests, companion diagnostics and other applications have led to a major boost for the DNA polymerase market. Manufacturers of DNA polymerases are entering into distribution agreements to extend product reach and collaborations to ensure they gain market share and remain competitive in global markets. Eukaryotic DNA polymerase segment is expected to hold the highest share of the market, as well as display strong growth, expanding at a CAGR of 6.7% over the forecast period. Among end use segments, molecular diagnostics companies are expected to hold the largest share of the global DNA polymerase market at over 31% market share in terms of revenue in 2027. However, the academic and research institutes segment is anticipated to expand at a robust growth rate of 7.4% over the forecast period.
High-fidelity DNA Polymerase Market: Overview
Based on the application type, the high-fidelity DNA polymerase market has been segmented into DNA cloning, SNAP Analysis, next generation sequencing applications and other applications. DNA cloning is expected to hold a large revenue share in the high-fidelity DNA polymerase market. Based on the end users, the high- fidelity DNA polymerase market has been segmented into research centers, academic institutions, biotechnology centers and others. Research centers are expected to hold a large revenue share in the overall market.
Global DNA Polymerase Market: Regional Analysis & Forecast
FMI’s report segments the global DNA polymerase market on the basis of region into North America, Western Europe, Eastern Europe, Latin America, Asia Pacific Excluding Japan, Japan, and the Middle East & Africa. This report assesses key trends driving each market segment and offers analysis and insights on the DNA polymerase market across specific regions. The market in North America is anticipated to dominate the global DNA polymerase market with maximum value share by end of 2027, accounting for over 56% in terms of revenue. In terms of value, the market in Latin America is expected to be the fastest growing, registering a CAGR of 7.8% over the forecast period. The market in Asia Pacific Excluding Japan is also expected to show a significant growth of 7.7% over the forecast period.
For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/ask-question/rep-gb-801
Global DNA Polymerase Market: Vendor Landscape
Some of the key competitors covered in this report include Thermo Fisher Scientific Inc, Roche Diagnostics, Agilent Technologies, Qiagen NV, Takara Bio Company, Merck KGaA, Genscript, Illumina, New England Biolabs, and Promega Corporation. These vendors in the global DNA polymerase market are expanding their business by launching new and innovative products tailored for both research and in-vitro applications. Companies are also focussing on emerging markets in Asia Pacific to increase their geographical presence and tap into various end use segments that have the ability to invest in R&D for life sciences as well as develop innovative diagnostics tools.
Neuroendocrine Carcinoma Treatment Market: FMI’s compelling study on the neuroendocrine carcinoma treatment market sheds light on the prominent dynamics influencing the growth trajectory for the upcoming forecast period 2019-2029 through detailed segmental and regional analyses.
Cancer Care Products Market: The cancer care products market report offers a 360-degree analysis, bringing to the fore insights that can help stakeholders identify key challenges and opportunities across the upcoming decade’s growth trajectory.
Superficial Radiation Therapy System Market: The global superficial radiation therapy system market is anticipated to surpass an impressive revenue threshold by the end of the forecast period ranging from 2020 to 2030, concludes FMI’s recently published research report on the market
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: firstname.lastname@example.org
For Media Enquiries: email@example.com